Anatara Lifesciences is developing non-antibiotic oral solutions for gastrointestinal diseases in animals and humans. Our lead product Detach™ is a natural product that will help address global concerns around the overuse of antibiotics in animals and their feed that is contributing to the rise of so-called “super bugs” that make infectious diseases harder to treat. The Anatara team has a strong track record in biological science as well as building and growing international biotech companies.
Latest news All news
Anatara Lifesciences is pleased to release its latest investor presentation and market update that will be delivered to investors over the next two weeks by CEO & Chairman, Dr Mel Bridges and Co-Founder and Chief Scientific Officer, Dr Tracey Mynott.
Please click here to view the ASX announcement and presentation.
Anatara Lifesciences is pleased to announce the following results from the Annual General Meeting held on 15th November 2016.
At today’s Annual General Meeting all Resolutions put to Shareholders were passed unanimously on a show of hands.
Please click here to view the ASX announcement.